Brown P W, Terz J J, King R, Lawrence W
Arch Surg. 1975 Jan;110(1):77-81. doi: 10.1001/archsurg.1975.01360070077013.
Ninety-five patients who underwent bilateral adrenalectomy for metastatic breast carcinoma are reviewed. An objective remission of tumor was observed in 66% of the patients over the age of 45 years with metastasis limited to soft tissue, osseous, or pulmonary system. In those patients below the age of 45, only 19% had remission irrespective of the sites of metastasis. Thirty-three patients were admitted with no "free interval," with objective remission occuring in 42%. This observation indicates that the "free interval" is not as striking a determinant in selecting adrenalectomy candidates as had been stressed by others. The serial treatment of adrenalectomy followed by chemotherapy after adrenalectomy failure or relapse was shown to objectively benefit 74% of 72 patients evaluated. Sulfokinase activity in breast cancer tissue was studied in 17 patients. The results were not as definitive as reported by others.
回顾了95例因转移性乳腺癌接受双侧肾上腺切除术的患者。在45岁以上、转移局限于软组织、骨骼或肺部系统的患者中,66%观察到肿瘤客观缓解。在45岁以下的患者中,无论转移部位如何,只有19%出现缓解。33例患者入院时无“无病间期”,其中42%出现客观缓解。这一观察结果表明,“无病间期”在选择肾上腺切除术候选者时并非像其他人所强调的那样是一个显著的决定因素。在72例接受评估的患者中,74%的患者在肾上腺切除术后失败或复发后接受肾上腺切除术并随后进行化疗的序贯治疗显示出客观获益。对17例患者的乳腺癌组织中的磺激酶活性进行了研究。结果不像其他人报道的那样明确。